If you are interested in autoreactive T-cell epitopes and the methods used to identify autoreactive T cells, this review is definitely worth your time.
The article highlights how ATMPs are reshaping the way we approach autoimmune diseases. These therapies aim to precisely target immune responses, moving away from broad immunosuppression toward antigen-specific interventions.
A central theme is the importance of T-cell epitopes, the specific fragments of antigens recognized by T cells, which play a key role in driving autoimmune responses when the immune system mistakenly targets self-proteins. Understanding and identifying these epitopes is therefore essential for designing therapies that can selectively modulate harmful immune activity without compromising overall immunity.
The review further explores emerging technologies that enable epitope discovery, including immunopeptidomics and computational prediction tools. These approaches are accelerating the identification of disease-relevant targets and opening new avenues for personalized and highly specific treatments.
Overall, the paper provides a clear and timely overview of how advances in epitope discovery and ATMP development are converging to create the next generation of precision therapies for autoimmune disorders.